- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Synchronize Clinical Trial and RWD Strategies
Now Available On Demand! Building the best! Learn how to leverage real-world evidence and the newest patient insights to ensure you are building the most comprehensive, compliant, and diverse clinical trials.
Register Free: http://www.pharmexec.com/pe_w/RWE
Event Overview:
This presentation will delve into the rapidly changing regulatory landscape of clinical trials, and how RWD and comprehensive patient data insights are supporting these changes. Learn how decentralized trials and synthetic control arms are delivering expedited outcomes, and how newly available patient demographics insights are ensuring diversity and inclusion while meeting new regulatory requirements. Lastly, participants will understand how to obtain these insights and incorporate them into their clinical trial designs using Komodo’s comprehensive software solutions.
Key Learning Objectives:
- How RWD can be leveraged to expedite clinical trials via decentralized trials and synthetic controls arms
- Incorporation of newly available patient demographic insights to ensure diversity, inclusion and regulatory compliance within your clinical trials
- Integration of complex data insights via automated technology
Who Should Attend:
Life sciences professionals with an interest in how to expedite clinical trials and ensure inclusivity by incorporating real-world data and novel patient data-insights into their pre-commercial workflows
Speakers
Kwame Marfo
MSI Lead, Clinical Development
Komodo Health
Kwame is the Market Strategy and Innovation Lead for Clinical Development at Komodo Health.
He has 15+ years of experience in the healthcare industry, working in strategy and operations leadership roles across manufacturing technical operations, commercial and R&D. Prior to Komodo, Kwame served as a Director of Insights and Analytics for Roche/Genentech’s Global Clinical Operations.
Kwame graduated with a BS in Chemical Engineering from Stanford University and an MBA in Corporate Strategy and Market Analysis from the University of California, Berkeley.
Learn More About Kwame’s Work:
Diversity in Clinical Trials: A Regulatory Imperative
Putting Data to Work: How RWE Can Deliver Speed, Insights, and Value for Clinical Trials
Generate Richer Insights Before and After the Trial With Real-World Data
Register Free: http://www.pharmexec.com/pe_w/RWE
